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Abstract
Alzheimer’s disease (AD) pathogenesis is associated with formation of amyloid fibrils caused by polymerization of the
amyloid b-peptide (Ab), which is a process that requires unfolding of the native helical structure of Ab. According to recent
experimental studies, stabilization of the Ab central helix is effective in preventing Ab polymerization into toxic assemblies.
To uncover the fundamental mechanism of unfolding of the Ab central helix, we performed molecular dynamics simulations
for wild-type (WT), V18A/F19A/F20A mutant (MA), and V18L/F19L/F20L mutant (ML) models of the Ab central helix. It was
quantitatively demonstrated that the stability of the a-helical conformation of both MA and ML is higher than that of WT,
indicating that the a-helical propensity of the three nonpolar residues (18, 19, and 20) is the main factor for the stability of
the whole Ab central helix and that their hydrophobicity plays a secondary role. WT was found to completely unfold by a
three-step mechanism: 1) loss of a-helical backbone hydrogen bonds, 2) strong interactions between nonpolar sidechains,
and 3) strong interactions between polar sidechains. WT did not completely unfold in cases when any of the three steps was
omitted. MA and ML did not completely unfold mainly due to the lack of the first step. This suggests that disturbances in
any of the three steps would be effective in inhibiting the unfolding of the Ab central helix. Our findings would pave the
way for design of new drugs to prevent or retard AD.
Citation: Ito M, Johansson J, Stro ¨mberg R, Nilsson L (2011) Unfolding of the Amyloid b-Peptide Central Helix: Mechanistic Insights from Molecular Dynamics
Simulations. PLoS ONE 6(3): e17587. doi:10.1371/journal.pone.0017587
Editor: Franca Fraternali, Kings College, London, United Kingdom
Received December 10, 2010; Accepted February 5, 2011; Published March 7, 2011
Copyright:  2011 Ito et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant (621-2009-4590) from the Swedish Research Council (http://www.vr.se/). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: lennart.nilsson@ki.se
Introduction
Amyloid b-peptide (Ab) was first isolated from meningeal vessels
of Alzheimer’s disease (AD) patients [1], and one year later, it was
recognized as the main component of the neuritic (senile) plaques
in AD patients’ brain tissue [2]. The amyloid cascade hypothesis
suggests that accumulation of Ab in the brain is the primary
influence driving AD pathogenesis [3,4,5]. According to this
hypothesis, cleavage of the amyloid precursor protein at the
membrane of a neuronal cell produces Ab, subsequent aggrega-
tion and fibril formation of Ab in extracellular fluid produce a
neuritic plaque, and neuronal death is caused by toxicity of
prefibrillar intermediates or mature fibrils, which eventually causes
AD. Despite many efforts, fundamental and practical treatments
and drugs for AD have not yet been found, even though several
drugs to help mask the symptoms of AD are already being used.
A recent experimental study [6] reported that, although
immunization with Ab resulted in clearance of the neuritic plaques
in AD patients, this did not prevent progressive neurodegeneration.
This suggests that it may be too late to cure or prevent AD after the
emergence of plaques. To find effective methods or drugs to prevent
AD, the mechanism of Ab fibril formation, which takes place before
the emergence of plaques, should be clarified in detail.
In early experimental studies [7,8,9,10] it was shown that Ab
consist of 39–42 amino acids, and that a short Ab(16–20) peptide
composed of the middle five residues (KLVFF) is capable of
binding to full-length Ab(1–40) [7]. By comparing the binding
capabilities of many peptide sequences for Ab(1–40), it was
indicated that KLVFF is a minimum sequence for formation of the
Ab aggregate [7,8]. In line with this, fluorescence-labeled KLVFF
was found to specifically recognize immobilized KLVFF [9,10].
Based on NMR structural data of Ab in various environments,
that is, membrane-water-medium-like environments [11,12,13]
and extracellular-fluid-like environments [14,15], and of an Ab
fibril [16], the middle region (15–24) of Ab, which includes the Ab
recognition element (KLVFF), is considered to unfold after
departing from the membrane to the extracellular fluid environ-
ment from an a-helix to a b-strand, accompanied by oligomer-
ization and polymerization of the unfolded Ab monomers into the
form of b-sheets.
Circular dichroism spectroscopy and electron microscopy
showed that the helical content of an a-helix/b-strand discordant
region (residues 16–23) of Ab(12–28) is increased by introducing
V18A/F19A/F20A replacements or by adding the tripeptide
KAD or phospho-L-serine, and this is associated with reduced
fibril formation [17]. Thus, it was suggested that stabilization of
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Similarly, a study of lung surfactant protein C (SP-C), whose
amyloid fibril formation is related to pulmonary alveolar
proteinosis, showed that substitutions of leucines for valines in
an a-helix/b-strand discordant region increase the helical content
and reduce amyloid fibril formation [18]. In a recent experimental
study it was shown that stabilization of the central a-helix of Ab(1–
40/42) by either of two classes of ligands, which were designed to
bind and stabilize the 13–26 region in an a-helical conformation,
counteracts Ab polymerization into toxic assemblies, prevents Ab
induced reduction in hippocampal c-oscillations, and increases
longevity as well as decreases locomotor dysfunction in a Drosophila
model of AD [19].
According to recent experimental studies [17,19], inhibiting
unfolding of the Aba -helix of the middle region (15–24) can be an
effectivestrategyto repress Ab aggregation andfibrilformation, and
isthereforea promisingstrategyfordevelopmentofdrugstoprevent
or slow AD. In order to efficiently develop drugs according to this
strategy, elucidation of the detailed molecular mechanism of the
unfolding of the Ab central helix is needed. However, this detailed
mechanism remains obscure, due to the instability of the Aba -helix
in the extracellular environment, and also because of experimental
limitations in analyzing details of processes involving rapid
structural changes of biomolecules. On the other hand, theoretical
methods can overcome such limitations, and properties of model
structures of short-lived species such as the Aba -helix in water can
be studied using molecular dynamics(MD) methods. To date, many
MD studies on the structure and dynamics of Ab have been
reported. These studies have mainly focused on oligomerization of
unfolded Ab [20,21,22,23,24,25,26], with a smaller number of
studies of Ab unfolding [27,28,29,30].
One recent MD study of the unfolding of Ab examined the
stability of helical forms of Ab(1–42) and analogues [27], and
indicated that the stability of the a-helical conformation of the
middle region of the V18A/F19A/F20A mutant Ab is higher than
that of the wild-type Ab, in agreement with experimental data
[17]. However, the detailed mechanisms for the unfolding of the a-
helical conformation of Ab and for the stabilization by V18A/
F19A/F20A replacements remain unclear.
In the present study, the unfolding of the Ab central helix
(residues 15–24) was investigated by MD simulations starting from
a-helical structures of Ab(13–26). The region (15–24) of Ab is of
interest since the KLVFF motif included in this region is capable of
binding to full-length Ab [7,8] and to the KLVFF motif itself [9,10],
and stabilization of this region in an a-helical conformation by
mutations or by ligands counteracts Ab polymerization into toxic
assemblies [17,19]. MD simulations were executed under aqueous-
solution conditions, because it is known that the unfolding of the Ab
central helix occurs when Ab is exposed to the extracellular fluid
environment. In order to gain a better understanding of the
molecular mechanism of the unfolding of the Ab central helix, the
wild-type (WT) Ab(13–26) model was compared with mutant
Ab(13–26) models with alanine (MA) or leucine (ML) replacements
at three nonpolar residues 18, 19, and 20. The effect of V18A/
F19A/F20A replacements [17] on the stability of the Ab central
helix has been reported previously, but that of V18L/F19L/F20L
has never been reported to date. Finding a simulation protocol that
is able to unfold the WT helix, but not the mutants, will also give us
a span where we can later on study, in detail, the interactions of
helix stabilizing ligands [17,19] with Ab.
Experimental studies [31,32,33,34] of peptides and proteins
which ultimately form organized structures such as amyloid fibrils
suggest that the aggregation propensity of such peptides and
proteins is associated with simple physicochemical properties of
individual amino acids, such as hydrophobicity, secondary
structure (a-helical and b-sheet) propensity, and charge. We
therefore examined the effects of replacements of the nonpolar
residues with two types of nonpolar residues (A and L) on the
stability of the Ab central helix. The rank order of the biological
hydrophobicity (determined by Hessa et al. [35] with membrane
insertion) is A,V,F,L. The hydrophobicity of A and L thus
brackets that of V and F. At the same time the rank order
(determined by Kallberg et al. [18] with amino acid distributions
in helices and b-strands using the Chou-Fasman method [36]) of
the a-helical propensity is V,F,L,A and that of the b-strand
propensity is just the opposite, A,L,F,V.
It has been suggested that aggregation of peptides and proteins
is generally promoted by hydrophobicity as such [37,38], because
hydrophobic regions of peptides and proteins are known to be
crucial for triggering the aggregation process and to form the core
of fibrils [37,38] including the Ab fibril [16,39]. However, because
the initial process of Ab fibril formation in vivo is the unfolding of
the Ab helix, this initial process may not necessarily have a
dependence on hydrophobicity but could mainly be dependent on
amino acid a-helical propensity. The whole process of Ab fibril
formation in vivo might then be highly influenced by the amino
acid a-helical propensity.
As to general properties of peptide a-helices, it is considered that
breaking of backbone O(i)-HN(i+4) hydrogen bonds is an early
event in unfolding of peptide a-helices [40,41,42]. For this to be
productive and lead to unfolding, it is also necessary to consider
other factors that may contribute to the stability of the folded and
unfolded states. Sidechain attractive interactions, or salt bridges,
between residues on the same side of the helix (i.e., from residue i to
residue i+4o ri+8, approximately [43]) are assumed to enhance the
stability of peptide a-helices [40,41,42]. To precisely elucidate a
possible mechanism for the unfolding of the Ab central helix, we
should consider not only breaking of a-helical backbone hydrogen
bonds but also other energetic factors such as sidechain interactions.
Through examination of the WT, MA, ML models, we tried to
reveal whether the a-helical propensity is the sole determining
factor or if the hydrophobicity affects the stability of the Ab central
helix. Furthermore, we present detailed mechanisms for the
unfolding of the Ab central helix and for the stabilization by the
replacement of the three nonpolar residues.
Methods
Preparation of Systems
Experimental data [11,12,13] have shown that the middle region
(15–24) of Ab adopts an a-helical conformation in membrane-
water-medium-like environments, and therefore initial model
structures of Ab(13–26), whose sequence is HHQKLVFFA-
EDVGS, were built in an a-helical conformation using the Insight
II program(version 2000) [44]. Since Ab(13–26) is a fragment of the
full peptide, the N- and C-termini in our model were made neutral
by capping with N-terminal acetyl and C-terminal amide groups,
respectively. The structures of the mutant Ab(13–26) models were
built by modifying the WT Ab(13–26) model with V18A/F19A/
F20A or V18L/F19L/F20L replacements.
According to the NMR structure (entry 1HZ3 [14] in the Protein
Data Bank [45]) of the unfolded Ab in water at pH 5.7, all of the
ionizable residues are in their charged states, where H13 and H14
are protonated. However, to take the pH dependence of histidine
into consideration, two variants of the WT, MA, and ML models, in
which both of H13 and H14 are protonated (WT
+,M A
+,a n dM L
+)
or deprotonated at the Nd atoms (WT
0,M A
0, and ML
0), were
prepared. The total charge of the models with protonated histidines
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solvated in a rhombic dodecahedron water box filled with TIP3P
[46] water molecules with a minimum solute-wall distance of 10 A ˚.
Water molecules with the oxygen atom less than 2.2 A ˚ from any
heavy peptide atom were deleted, and each system was neutralized
by adding 1 chloride or 1 sodium counterion.
MD Simulations
All calculations were carried out using the CHARMM22/
CMAP force field [47,48,49] with the CHARMM program
[50,51]. The SHAKE [52] algorithm was applied to fix all
covalent bonds containing a hydrogen atom allowing a 2 fs
timestep to be used in the integration of Newton’s equations. The
nonbonded (van der Waals and Coulomb) interaction energies and
forces were smoothly shifted to zero at 12 A ˚ using the atom-based
force-shift method [53,54], and the nonbonded list was construct-
ed with a cutoff of 16 A ˚ and was updated every time any atom
moved by more than 2 A ˚ since the last update. Before MD
simulations were carried out, structures of the solvated systems
were optimized by 500 steps of steepest descent energy
minimization with a harmonic restraint of 20 kcal/mol/A ˚ 2 on
Ab followed by 1500 steps of adopted basis Newton-Raphson
energy minimization without a harmonic restraint on Ab. After
the systems were heated up to 300, 330, or 360 K gradually for
50 ps, five or ten independent 20 ns MD simulations were carried
out (Table 1) for a total of 1.2 ms of simulation to increase
sampling [55]. The MD simulations were performed for the
optimized systems under periodic boundary conditions at a
constant pressure (1 atm) using the Langevin piston method [56]
with piston mass 400 amu, collision frequency 20 ps
21 and bath
temperature (300, 330, or 360 K). The average temperature was
checked every 4 ps, and was found to remain within 5 K of the
target temperature after the heating MD run. Fast table lookup
routines for non-bonded interactions [57] were used to increase
speed of the MD simulations. During the MD simulations, no
harmonic restraints were imposed on any molecule in the systems,
and coordinates were saved every 1 ps.
Analyses
All analyses were carried out using every 10 ps of the
trajectories after the heating time of the MD simulations, except
as otherwise stated. Visualization of the structural change of the
Ab models during MD simulations was carried out by using the
visual molecular dynamics (VMD) software (version 1.8.6) [58].
To examine the structural change of the Ab models numeri-
cally, the root-mean-square deviation (RMSD) and radius of
gyration (Rg) were calculated for the middle region (15–24) of the
Ab models, thus large fluctuations of the RMSD and Rg due to the
mobile N- and C-termini were eliminated. Before the RMSD
measurements, overall rotation and translation were removed by
least-squares superposition using coordinates of all heavy atoms of
the initial energy-minimized structure obtained prior to the MD
simulations. The RMSD was calculated for backbone heavy atoms
against the initial energy-minimized coordinates and the Rg was
calculated for all atoms along the MD simulation time.
To discriminate the type or the pattern of the Ab structure, the
number of a-helical backbone hydrogen bonds (aHBs) in the
middle region (15–24) was calculated, using the criterion acceptor-
hydrogen distance ,2.4 A ˚ to define the existence of a hydrogen
bond [41]. The six aHBs in the middle region are numbered
sequentially from 1 to 6 starting with the 15–19 residue pair.
To indicate the driving forces for the Ab unfolding, energy
profiles of the Ab models were calculated, focusing in particular on
the nonbonded interaction energies (van der Waals and Coulomb)
between residues, separated into interaction energies between the
seven polar residues (Ep-p) and between the seven nonpolar residues
(Enp-np). The interaction energiesbetween thepolarresiduesandthe
nonpolarresidues were not focused on,sincethey do not exhibit any
notable changes during the simulations. For the calculations of Ep-p
and Enp-np, the interaction energy between one polar or nonpolar
residue and the other six polar or nonpolar residues was calculated,
and summation of the interaction energies of the seven polar or
nonpolar residues was divided by two to avoid double counting of
the interaction energy. In addition, Enp-np was analyzed in detail at
the residue level to find which nonpolar residues mainly contribute
to the nonpolar-nonpolar interactions.
Results
Ab Unfolding
Stability of the a-Helical Conformation of WT. To
examine at which temperature the unfolding of the WT peptide
can be observed in the 20 ns MD simulations, five independent
simulations at 300 K, five independent simulations at 330 K, and
ten independent simulations at 360 K were performed for each
WT model (WT+ and WT0).
Similar tendencies were observed for WT
+ and WT
0 in the
mean RMSD averaged over all trajectories (,RMSD.) (Fig. 1).
The ,RMSD. of both WT
+ and WT
0 at 360 K increased in the
Table 1. Models and conditions of the MD simulations.
name of model residues 18–20 state of histidines temperature (K) length (ns)/simulation number of simulations
WT
+ VFF protonated 300 20 5
330 20 5
360 20 10
WT
0 VFF neutral 300 20 5
330 20 5
360 20 10
MA
+ AAA protonated 360 20 5
MA
0 AAA neutral 360 20 5
ML
+ LLL protonated 360 20 5
ML
0 LLL neutral 360 20 5
doi:10.1371/journal.pone.0017587.t001
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330 K the ,RMSD. remained relatively small during 20 ns
(Fig. 1). The fluctuations of the ,RMSD. of both WT
+ and WT
0
at 360 K are small, particularly in the last 2 ns. The ,RMSD. of
both WT
+ and WT
0 at 360 K are on average more than 1.2 A ˚
larger than at 300 K and 330 K in the last 2 ns (Fig. 1). By visual
inspection of the structures, it was found that the WT peptide
maintained its middle region (15–24) in the initial a-helical
conformation during the whole 20 ns simulations in most of the
trajectories at 300 K and at 330 K, but at 360 K the a-helical
conformation was lost in several trajectories.
The average RMSD and the average number of aHBs of the
last 2 ns at 360 K showed three types (A, B, and C) of behavior
(Table 2). The seven trajectories in group A have relatively small
(,2.0 A ˚) RMSD and 2 to 4 aHBs, suggesting that the peptide
maintained the initial a-helical conformation during the whole
simulations or refolded by the end of the simulations. The eight
trajectories in group B have relatively large RMSD ($2.0 A ˚) and 1
to 3 aHBs, indicating partial unfolding of the peptide. The five
trajectories in group C have relatively large RMSD ($4.0 A ˚) and
no aHBs, suggesting complete unfolding of the peptide. Visual
inspection of the structures confirmed that, by the end of the
simulations at 360 K, the peptide refolded (though it partially
unfolded during the simulations) in the seven A trajectories,
partially unfolded in the eight B trajectories, and completely
unfolded in the five C trajectories.
Unfolding Mechanism of WT. Structural and energetic
aspects of the WT trajectories were analyzed in detail, in order to
understand how the Ab central helix completely unfolds. One WT
trajectory (WT+4) leading to complete unfolding is described in
detail, followed by a summary for the other four trajectories
(WT+7, WT+9, WT01, and WT09) that also displayed complete
unfolding.
In WT
+4, a marked increase in RMSD at around 5 ns (from
about 1.5 to 5.5 A ˚) is followed by an increase in Rg at around
12 ns (from about 7 to 9 A ˚) (Fig. 2A). Since RMSD was calculated
for only backbone heavy atoms of the middle region while Rg was
calculated for all atoms of the middle region, this shows that the
middle region adopts a conformation with a stretched backbone
and interacting sidechains from around 5 to 12 ns. After 12 ns,
both RMSD and Rg are large, consistent with a fully extended
conformation. The complete unfolding thus was triggered at
around 5 ns in the WT
+4 trajectory, and we inspected the time
courses of several variables (number of aHBs, interaction energies
between nonpolar (Enp-np) and polar (Ep-p) sidechains) of the
trigger point (around 5 ns) to find changes in these variables that
were of a larger magnitude than the high-frequency fluctuations.
Just before 5 ns the number of aHBs decreases from around 6
to 1 (Fig. 2B). All aHBs except for aHB1 are present almost
constantly before 4.28 ns, but from 5.21 ns they are all broken
until the end of the 20 ns simulation (Fig. 2C). The most favorable
Enp-np (the deepest minimum in Enp-np) occurs at 4.59 ns (Fig. 2D),
close to the time of the large change in the number of aHBs.
However, Enp-np at 4.28 ns when the number of aHBs starts to
decrease is similar to Enp-np at the beginning of the simulation,
which is around 10 kcal/mol less favorable than the Enp-np
Figure 1. Mean RMSD (,RMSD.) of the middle region (15–24) of the WT Ab models. The ,RMSD. calculated for the WT
+ (A) and WT
0 (B)
models are shown. The ,RMSD. of each WT model at 300 K (light gray lines) or 330 K (dark gray lines) was calculated by using the five trajectories
(trajectories 1–5), and that at 360 K (black lines) was calculated by using the ten trajectories (trajectories 1–10).
doi:10.1371/journal.pone.0017587.g001
Table 2. Average RMSD (in A ˚) and average number of aHBs
during the last 2 ns of 20 ns of the MD simulations calculated
for WT at 360 K.
average RMSD
average number
of aHBs group
a
trajectory WT
+ WT
0 WT
+ WT
0 WT
+ WT
0
1 2.59 4.36 2.4 0.1 B C
2 2.79 1.25 2.8 4.1 B A
3 2.20 1.35 2.5 3.8 B A
4 5.25 1.14 0.0 3.6 C A
5 3.84 4.37 0.9 1.6 B B
6 2.29 1.40 1.8 4.1 B A
7 4.85 1.23 0.4 3.8 C A
8 3.18 3.59 1.8 1.4 B B
9 4.89 4.02 0.1 0.0 C C
10 1.24 1.82 4.2 2.6 A A
mean value
b 3.31 2.45 1.7 2.5
SD
c 1.35 1.43 1.3 1.6
aThe trajectories are classified into three groups: A) RMSD,2.0 A ˚ and
2#aHBs#6, B) RMSD$2.0 A ˚ and 1#aHBs#4, and C) RMSD$4.0 A ˚ and
aHBs<0.
bMean values were calculated by using the ten average values obtained for
each model.
cStandard deviation (SD) were calculated by using the ten average values
obtained for each model.
doi:10.1371/journal.pone.0017587.t002
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number of aHBs, Enp-np, and Ep-p, in this order, thus exhibit
notable changes (Table 3).
The peptide conformations which were formed when the
number of aHBs, Enp-np, and Ep-p changed were analyzed in detail
(Fig. 2F). At 4.28 ns the backbone of the middle region of the
peptide is helical and straight, even though three out of the six
aHBs are broken. At 4.59 ns the backbone of the middle regions is
unwound, and the sidechains of the nonpolar residues L17, V18,
F19, F20, A21, and V24 form a hydrophobic cluster. At 5.29 ns
the backbone of the middle region is more unwound forming a
bent conformation, with a salt bridge between residues K16 and
D23 (the Nf(K16)-Cc(D23) distance is 3.36 A ˚ vs 8.86 A ˚ in the
initial energy-minimized structure). The above structural data
show that, in WT
+4, after at least three out of the six aHBs were
broken, the backbone was unwound by interactions between the
sidechains of the nonpolar residues and further unwound by
subsequent interactions between the sidechains of the polar
residues.
Once the backbone is fully unwound and becomes more
flexible, the middle region of the peptide changes between fully
extended and compact conformations (Fig. 2F, right side). The
total interaction energy between all residues calculated for the
compact conformation is about 10 kcal/mol more favorable than
the total energies calculated for the fully extended conformations.
This indicates that in the absence of intermolecular interactions
with other Ab molecules or other molecular species, the
completely unfolded middle region of Ab can be stabilized by
intramolecular interactions.
Altogether, in the WT
+4 trajectory, the peptide completely
unfolded through three steps: 1) loss of a-helical backbone
hydrogen bonds, 2) strong interactions between sidechains of
nonpolar residues, and 3) strong interactions between sidechains of
polar residues. At the second step, a hydrophobic cluster
composed of the sidechains of the nonpolar residues L17, V18,
F19, F20, A21, and V24 allowing the backbone of the middle
region to unwind, was formed, and facilitated the subsequent
structural changes.
Applying the same detailed structural and energetic analyses,
the WT peptide was also found to completely unfold through the
same three steps in the other four trajectories (WT
+7, WT
+9,
WT
01, and WT
09), regardless of the protonation states of the
Figure 2. Structural and energetic changes of WT
+4. The RMSD and Rg (A), the number of aHBs (B), and the backbone O-HN distances of the
aHB pairs 1–6 (C) calculated for the middle region (15–24) of the Ab model are shown. The nonbonded interaction energies including Enp-np (D) and
Ep-p (E) are also shown. The structure obtained at 4.28 ns when the number of aHBs starts to decrease, that obtained at 4.59 ns with the Enp-np
minimum (273.58 kcal/mol), and that obtained at 5.29 ns with the notably low Ep-p (2116.13 kcal/mol) are displayed in the black, red, and blue
boxes, respectively (F). The structures obtained at 12.72, 16.56, and 19.32 ns with relatively large (9.93 A ˚), small (6.48 A ˚), and large (9.65 A ˚)R g,
respectively, are displayed from the top the bottom in the grey boxes. The initial energy-minimized structure and the structure obtained at 20.00 ns
are also displayed at the top and the bottom, respectively. The positions of all the nonpolar residues (thick lines) and those of the polar residues (lines
and balls) which are closely located are indicated.
doi:10.1371/journal.pone.0017587.g002
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and S4). The listed time (Table 3) of each step corresponds to the
time at which the change in the number of aHBs, in Enp-np,o ri n
Ep-p is larger than the rapid fluctuations.
In all the five WT trajectories which exhibited complete
unfolding, step 2 occurred within 0.5 ns after step 1, with step 3
following within 1.5 ns after step 2; the RMSD increased through
the three steps, showing that the conformational change of the
backbone of the middle region of the peptide increased as the
process advanced (Table 3). At step 1 in the five trajectories, the
backbone of the middle region of the peptide is still helical, even
though three or more aHBs are broken. At step 2 in the five
trajectories, the backbone of the middle region is unwound and
sidechains of the nonpolar residues (L17, V18, F19, F20, A21, and
V24) form a hydrophobic cluster (Fig. 2F, S1F, S2F, S3F, and
S4F). Noteworthy is that the shapes of the hydrophobic clusters
(Fig. 2F and S1F) formed at step 2 in two trajectories (WT
+4 and
WT
+7) are quite similar. At step 3 in four trajectories (excluding
WT
01), the N-terminal polar residues interact with the C-terminal
polar residues, though at step 3 in one trajectory (WT
01), the N-
and C-terminal polar residues interact locally with the other N-
and C-terminal polar residues, respectively. It would be difficult
for the N- and C-terminal polar residues to approach each other if
the backbone did not become flexible before step 3, because the
polar residues are separated by the central hydrophobic region
(17–21) including the bulky nonpolar residues (L17, F19, F20).
Thus, it seems that steps 1 and 2 are important in inducing the
drastic conformational change of the WT peptide at step 3.
Additionally, the per-residue Enp-np at step 2 of the complete
unfolding events in the five trajectories was analyzed (Table 4), to
examine which nonpolar residues are important in forming a
hydrophobic cluster allowing the backbone of the middle region to
unwind. Enp-np of L17, V18, F19, F20, A21, and V24 are more
favorable than Enp-np of G25 at step 2 in all five trajectories, and
Enp-np of F19 and, in particular, F20 are favorable (,220.0 kcal/
mol). This indicates that L17, V18, A21, V24, and especially F19
Figure 3. Mean RMSD (,RMSD.) of the middle region (15–24) of the WT, MA, and MT Ab models. The ,RMSD. calculated for the WT
+,
MA
+, and ML
+ models (A), and the WT
0,M A
0, and ML
0 models (B) at 360 K are shown. The ,RMSD. of each WT model (black lines) was calculated by
using the ten trajectories (trajectories 1–10), and those of each MA (blue lines) or ML (green lines) model was calculated by using the five trajectories
(trajectories 1–5).
doi:10.1371/journal.pone.0017587.g003
Table 5. Average RMSD (in A ˚) and average number of aHBs
during the last 2 ns of 20 ns of the MD simulations calculated
for MA at 360 K.
average RMSD
average number of
aHBs group
a
trajectory MA
+ MA
0 MA
+ MA
0 MA
+ MA
0
1 0.74 1.24 4.4 4.3 A A
2 1.03 1.23 4.1 4.5 A A
3 4.72 4.03 1.9 1.1 B B
4 0.83 0.64 4.2 4.4 A A
5 2.23 0.77 3.6 4.2 B A
mean value
b 1.91 1.58 3.6 3.7
SD
c 1.68 1.39 1.0 1.5
aThe trajectories are classified into three groups: A) RMSD,2.0 A ˚ and
2#aHBs#6, B) RMSD$2.0 A ˚ and 1#aHBs#4, and C) RMSD$4.0 A ˚ and
aHBs<0.
bMean values were calculated by using the five average values obtained for
each model.
cStandard deviation (SD) were calculated by using the five average values
obtained for each model.
doi:10.1371/journal.pone.0017587.t005
Table 6. Average RMSD (in A ˚) and average number of aHBs
during the last 2 ns of 20 ns of the MD simulations calculated
for ML at 360 K.
average RMSD
average number
of aHBs group
a
trajectory ML
+ ML
0 ML
+ ML
0 ML
+ ML
0
1 2.97 0.69 1.8 4.3 B A
2 0.85 1.39 4.6 4.3 A A
3 1.27 2.46 4.2 2.3 A B
4 1.25 3.18 4.0 1.1 A B
5 1.10 1.24 4.5 4.3 A A
mean value
b 1.49 1.79 3.8 3.2
SD
c 0.84 1.01 1.1 1.5
aThe trajectories are classified into three groups: A) RMSD,2.0 A ˚ and
2#aHBs#6, B) RMSD$2.0 A ˚ and 1#aHBs#4, and C) RMSD$4.0 A ˚ and
aHBs<0.
bMean values were calculated by using the five average values obtained for
each model.
cStandard deviation (SD) were calculated by using the five average values
obtained for each model.
doi:10.1371/journal.pone.0017587.t006
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17587and F20, contribute significantly to the disruption of the a-helical
conformation of the WT peptide by forming the hydrophobic
clusters.
A three-step mechanism was thus proposed for the unfolding of
the Ab central helix based on similar structural and energetic
features observed in the complete unfolding events of five WT
trajectories. By the same detailed structural and energetic analyses,
it was found that all of the partial-unfolding/refolding events in the
WT trajectories lacked at least one of the steps of the three-step
mechanism, indicating that all the three steps are necessary for the
complete unfolding of the Ab central helix.
Effects of Alanine or Leucine Replacements on Ab
Unfolding
Stability of the a-Helical Conformation of MA and
ML. MD simulations of the V18A/F19A/F20A (MA) and
V18L/F19L/F20L (ML) models of Ab(13–26) were carried out
at 360 K. Five independent MD simulations were performed for
each mutant Ab model (Table 1). In comparison to WT, similar
tendencies were observed for MA and ML in the mean RMSD
averaged over all trajectories (,RMSD.) (Fig. 3). In the first 2 ns,
the ,RMSD. of MA and ML are almost constant around 1 A ˚,
while for of WT there is an increase to 2 A ˚. The ,RMSD. of
MA and ML are smaller than those for WT in the last 2 ns (Fig. 3),
showing that the conformations of the MA and ML peptides did
not change so much by 20 ns at 360 K as the conformation of the
WT peptide did under the same conditions.
Similar tendencies were observed for MA and ML in the
average RMSD and in the average number of aHBs during the
last 2 ns (Tables 5 and 6), in comparison to WT (Table 2). For the
MA and ML trajectories, the RMSD is 0.7 to 1.8 A ˚ smaller on
average, and the number of aHBs is on average 1 to 2 larger on
average, compared to the WT trajectories. Together with visual
inspection of the structures, it was found that the MA and ML
peptides maintained the initial a-helical conformations during the
whole simulations or refolded by the end of the simulations in the
seven MA and seven ML trajectories in the group A, and that they
partially unfolded in the remaining three MA and three ML
trajectories in the group B. Furthermore, for none of the MA and
ML trajectories the average number of aHBs is smaller than 1,
showing that neither of the MA and ML peptides completely
unfolded in any of the ten MA trajectories or the ten ML
trajectories by the end of the simulations, while the WT peptide
completely unfolded in five out of the twenty WT trajectories.
Taken together this indicates that the stability of the a-helical
conformations of both the MA and ML peptides is higher than
that of the WT peptide, regardless of the protonation states of the
histidine residues.
The V18A/F19A/F20A replacements can stabilize the a-helical
conformation of the middle region of Ab, in agreement with
experimental data for Ab(12–28) [17] and with results of previous,
shorter, MD simulations for the WT and MA models of full-length
Ab(1–42) [27]. V18L/F19L/F20L replacements can also stabilize
the a-helical conformation of the middle region of Ab, similarly to
results for the middle region of SP-C [18]. It is noteworthy that the
stability of the a-helical conformations of both the MA and ML
peptides is higher than that of WT. This tendency is consistent
with a higher a-helical propensity [18] for the three nonpolar
residues (18, 19, and 20) of MA and ML than for the
corresponding residues of WT. Thus, the stability of the Ab
central helix is strongly affected by the a-helical propensity of the
three nonpolar residues (18, 19, and 20), whereas there is little
effect of hydrophobicity, as such, for loss of helicity.
In addition, the distribution of the number of aHBs was
analyzed using the full 20 ns of all simulations (Fig. 4). The
distribution is shifted towards higher numbers for MA and ML
compared to WT, and in particular, the frequency of no aHBs is
much lower for MA and ML. The frequency of no aHBs of MA
and ML is one-fourth or lower than one-fourth of that of WT. In
contrast, the frequency of six aHBs of MA and ML is two to three
times as high as that of WT. From the distribution of the number
of aHBs, it seems that the first step (sufficient loss of aHBs) of the
three-step mechanism would be more difficult for the MA and ML
peptides than for the WT peptide, resulting in the stabilization of
the a-helical conformations of the MA and ML peptides.
Structural and Energetic Features of MA and ML. The
structural and energetic aspects of the MA and ML trajectories
were analyzed in detail, in order to understand how V18A/F19A/
F20A and V18L/F19L/F20L replacements stabilize the Ab
central helix. Details for one MA (MA+2) trajectory and one
ML (ML+3) trajectory are described below.
In MA
+2, RMSD is relatively large from about 3 to 17 ns, and a
marked increase in RMSD is observed at around 7 ns, though Rg is
almost constant during the whole simulation (Fig. 5A). The six aHBs
are kept almost constantly during the whole simulation (Fig. 5B and
5C). Enp-np is almost constant (Fig. 5D) and a hydrophobic cluster
Figure 4. Average frequencies of the appearance of the structures with n aHBs (n=0–6) in the middle region (15–24) of the WT, MA,
and ML Ab models. The average frequencies calculated for the WT
+,M A
+, and ML
+ models (A) and the WT
0,M A
0, and ML
0 models (B) at 360 K are
shown. The average frequencies of each WT model (black bars) were calculated by using the ten trajectories (trajectories 1–10), and those of each MA
(blue bars) or ML (green bars) model were calculated by using the five trajectories (trajectories 1–5).
doi:10.1371/journal.pone.0017587.g004
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sidechains of the three replaced nonpolar residues cannot reach
those of other nonpolar residues to form a hydrophobic cluster. Ep-p
is low from about 3 to 17 ns when RMSD is large, and a notable
change in Ep-p is observed at around 7 ns when the marked increase
in RMSD occurs (Fig. 5E). At 6.84 ns when Ep-p is minimum in
MA
+2, salt bridges H14-E22 and K16-D23 are formed (Fig. 5F).
Although the backbone of residues 15–19 is unwound by the
interactions between the sidechains of the polar residues, the
backbone of residues 20–24 is still helical at 6.84 ns. The a-helical
conformation of the middle region of the MA peptide is fully
reconstructed at the end of the simulation in MA
+2 (Fig. 5F).
In ML
+3, several small increases in RMSD are observed before
15 ns, though Rg is almost constant during the whole simulation
(Fig. 6A). The six aHBs are kept almost constantly during the whole
simulation (Fig. 6B and 6C). Enp-np is almost constant (Fig. 6D) and
a hydrophobic cluster was not observed during the whole
simulation, suggesting that the sidechains of the three leucine
residues cannot form a hydrophobic cluster, while the peptide is in
helical conformation. Since there is a higher tendency, than for the
wild type, to retain aHBs there is also not enough loss of aHBs to
form hydrophobic clusters after such an event. A notable change in
Ep-p is observed at around 13 ns when one of the increases in
RMSD occurs (Fig. 6E). At 12.70 ns when Ep-p is minimum in
ML
+3, a salt bridge K16-D23 is formed (Fig. 6F). Although the
backbone of the middle region of the peptide is bent by the
interactions between the sidechains of the polar residues, it is still
helical with a kink at residue 20 at 12.70 ns. The a-helical
Figure 5. Structural and energetic changes of MA
+2. The RMSD and Rg (A), the number of aHBs (B), and the backbone O-HN distances of the
aHB pairs 1–6 (C) calculated for the middle region (15–24) of the mutant Ab model are shown. The nonbonded interaction energies including Enp-np
(D) and Ep-p (E) are also shown. The structure of MA
+2 obtained at 6.84 ns with the Ep-p minimum (2173.43 kcal/mol) is displayed in the blue box (F).
The initial energy-minimized structure and the structure obtained at 20.00 ns are also displayed at the top and the bottom, respectively. The
positions of all the nonpolar residues (thick lines) and those of the polar residues (lines and balls) which are closely located are indicated.
doi:10.1371/journal.pone.0017587.g005
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reconstructed at the end of the simulation in ML
+3 (Fig. 6F).
To summarize, although the backbones of the middle regions of
the MA and ML peptides were, temporarily, partially unwound by
the interactions between the sidechains of the polar residues, they
were not unwound so much as the backbone of the WT peptide in
the complete unfolding events was, because all the aHBs were
present almost constantly during the whole simulations in MA
+2
and ML
+3. This indicates that primarily the lack of step 1 of the
three-step mechanism resulted in the stabilization of the a-helices
in both MA
+2 and ML
+3. This lack of step 1 was also found in the
other six MA and five ML trajectories in which a-helical
conformations of the MA and ML peptides were maintained
during the whole simulations or were reconstructed by the end of
the simulations.
Discussion
The unfolding process of the Ab central helix (residues 15–24),
which is a prerequisite for the amyloid fibril formation in AD, was
investigated by MD simulations of wild-type (WT) Ab(13–26) and
two mutant forms with alanine (MA) or leucine (ML) substitutions
at the three nonpolar residues (18, 19, and 20). As indicated
mainly by the backbone RMSD vs the initial structure and the
existence of aHBs, the WT peptide unfolded (completely or
partially) to a large extent in simulations at 360 K (the
temperature used to achieve unfolding in the 20 ns MD
trajectories), whereas the MA and ML peptides essentially
remained stable a-helices, indicating that the a-helical propensity
of the three nonpolar residues (18, 19, and 20) is the dominating
factor for the stability of the Ab central helix. While there is little
Figure 6. Structural and energetic changes of ML
+3. The RMSD and Rg (A), the number of aHBs (B), and the backbone O-HN distances of the
aHB pairs 1–6 (C) calculated for the middle region (15–24) of the mutant Ab model are shown. The nonbonded interaction energies including Enp-np
(D) and Ep-p (E) are also shown. The structure of ML
+3 obtained at 12.70 ns with the Ep-p minimum (2102.95 kcal/mol) is displayed in the blue box (F).
The initial energy-minimized structure and the structure obtained at 20.00 ns are also displayed at the top and the bottom, respectively. The
positions of all the nonpolar residues (thick lines) and those of the polar residues (lines and balls) which are closely located are indicated.
doi:10.1371/journal.pone.0017587.g006
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PLoS ONE | www.plosone.org 10 March 2011 | Volume 6 | Issue 3 | e17587effect of the hydrophobicity on loss of helicity (there is also slight
tendency for this when comparing the data for the MA and ML
peptides in Figures 3 and 4), this can play a role in events taking
place after initial unwinding of the helix. If residues have a high
helical propensity hydrophobicity can even stabilize helices
further, provided there is interaction between them.
That helical propensity is the main factor for loss of helicity is
consistent with previous experimental data for Ab(12–28) [17] and
previous simulation data for full-length Ab(1–42) [27] and also
similar to experimental results for the middle region of SP-C [18].
The presented simulations thus further substantiate the impor-
tance of amino acid a-helical propensity in predicting sequences of
Ab-analogous or Ab-variant peptides which may form amyloid
fibrils in vivo.
Based on detailed structural and energetic analyses of the
unfolding events observed in the WT trajectories, we suggest that
complete unfolding occurs via a three-step mechanism, where the
subsequent steps are dependent on that step 1 is completed: 1)
sufficient loss of a-helical backbone hydrogen bonds, 2) strong
interactions between nonpolar sidechains, and 3) strong interac-
tions between polar sidechains. We identified a hydrophobic
cluster composed of the sidechains of L17, V18, F19, F20, A21,
and V24, that allowed the backbone of the middle region to
unwind, at the second step. We found that especially residues F19
and F20 contribute significantly to the stabilization of the
hydrophobic cluster. We consider that this hydrophobic cluster
facilitate the transition to the third step with interactions between
polar residues which are separated by the central hydrophobic
region (17–21). The Ab central helix did not completely unfold in
cases when any of the three steps was missing. Thus, we suggest
that the complete unfolding of this helix may be inhibited not only
by preventing breakage of a-helical backbone hydrogen bonds (the
first step) but also by disturbing interactions between nonpolar
sidechains (the second step) or between polar sidechains (the third
step).
In addition, the properties of the MA and ML peptides were
compared to those of the WT peptide to examine the effects of
alanine and leucine replacements on the Ab unfolding mechanism.
For both MA and ML the structures which possess all aHBs in the
middle region appeared two to three times as often as for WT
during the whole simulations, suggesting that the first step of the
three-step mechanism would be more difficult for the MA and ML
peptides than for the WT peptide. By detailed structural and
energetic analyses of the MA and ML trajectories, we confirmed
that the alanine and leucine replacements are effective in
preventing the first step, associated with the higher a-helical
propensity of these residues, to inhibit the unfolding of the Ab
central helix.
The quantitative assessments made from our MD simulations
are in good agreement with available experimental data for the
alanine mutant, which lends support to our findings for the leucine
mutant as well as for the proposed three-step unfolding
mechanism.
Supporting Information
Figure S1 Structural and energetic changes of WT
+7.
The RMSD and Rg (A), the number of aHBs (B), and the
backbone O-HN distances of the aHB pairs 1–6 (C) calculated for
the middle region (15–24) of the Ab model are shown. The
nonbonded interaction energies including Enp-np (D) and Ep-p (E)
are also shown. The structure obtained at 0.10 ns when the
number of aHBs starts to decrease, that obtained at 0.15 ns with
the Enp-np minimum (266.32 kcal/mol), and that obtained at
1.36 ns with the notably low Ep-p (2113.67 kcal/mol) are
displayed in the black, red, and blue boxes, respectively (F). The
structures obtained at 2.11, 5.90, and 10.13 ns with relatively large
(9.37 A ˚), small (6.48 A ˚), and large (9.69 A ˚)R g, respectively, are
displayed from the top the bottom in the grey boxes. The initial
energy-minimized structure and the structure obtained at 20.00 ns
are also displayed at the top and the bottom, respectively. The
positions of all the nonpolar residues (thick lines) and those of the
polar residues (lines and balls) which are closely located are
indicated.
(TIF)
Figure S2 Structural and energetic changes of WT
+9.
The RMSD and Rg (A), the number of aHBs (B), and the
backbone O-HN distances of the aHB pairs 1–6 (C) calculated for
the middle region (15–24) of the Ab model are shown. The
nonbonded interaction energies including Enp-np (D) and Ep-p (E)
are also shown. The structure obtained at 15.21 ns when the
number of aHBs starts to decrease, that obtained at 15.53 ns with
the notably low Enp-np (268.76 kcal/mol), and that obtained at
16.43 ns with the notably low Ep-p (270.04 kcal/mol) are
displayed in the black, red, and blue boxes, respectively (F). The
structures obtained at 17.72, 18.32, and 19.07 ns with relatively
large (8.64 A ˚), small (6.17 A ˚), and large (9.09 A ˚)R g, respectively,
are displayed from the top the bottom in the grey boxes. The
initial energy-minimized structure and the structure obtained at
20.00 ns are also displayed at the top and the bottom, respectively.
The positions of all the nonpolar residues (thick lines) and those of
the polar residues (lines and balls) which are closely located are
indicated.
(TIF)
Figure S3 Structural and energetic changes of WT
01.
The RMSD and Rg (A), the number of aHBs (B), and the backbone
O-HN distances of the aHB pairs 1–6 (C) calculated for the middle
region (15–24) of the Ab model are shown. The nonbonded
interaction energiesincludingEnp-np (D) and Ep-p(E)arealso shown.
The structure obtained at 17.05 ns when the number of aHBs starts
to decrease, that obtained at 17.15 ns with the Enp-np minimum
(274.15 kcal/mol), and that obtained at 18.15 ns with the notably
lowEp-p(295.04 kcal/mol)aredisplayed intheblack,red, and blue
boxes, respectively (F). The structures obtained at 18.75, 19.16, and
19.64 ns with relatively large (8.70 A ˚), small (6.78 A ˚), and large
(8.94 A ˚)R g, respectively, are displayed from the top the bottom in
the grey boxes. The initial energy-minimized structure and the
structure obtained at 20.00 ns are also displayed at the top and the
bottom, respectively. The positions of all the nonpolar residues
(thick lines)and those ofthepolar residues(linesand balls)whichare
closely located are indicated.
(TIF)
Figure S4 Structural and energetic changes of WT
09.
The RMSD and Rg (A), the number of aHBs (B), and the backbone
O-HN distances of the aHB pairs 1–6 (C) calculated for the middle
region (15–24) of the Ab model are shown. The nonbonded
interaction energiesincludingEnp-np (D) and Ep-p(E)arealso shown.
The structure obtained at 9.09 ns when the number of aHBs starts
to decrease, that obtained at 9.20 ns with the Enp-np minimum
(273.54 kcal/mol), and that obtained at 10.65 ns with the notably
lowEp-p(287.82 kcal/mol)aredisplayed intheblack,red, and blue
boxes, respectively (F). The structures obtained at 12.90, 16.60, and
17.22 ns with relatively large (9.19 A ˚), small (6.42 A ˚), and large
(8.96 A ˚)R g, respectively, are displayed from the top the bottom in
Unfolding of the Amyloid b-Peptide Central Helix
PLoS ONE | www.plosone.org 11 March 2011 | Volume 6 | Issue 3 | e17587the grey boxes. The initial energy-minimized structure and the
structure obtained at 20.00 ns are also displayed at the top and the
bottom, respectively. The positions of all the nonpolar residues
(thick lines)andthose ofthe polarresidues (lines and balls)which are
closely located are indicated.
(TIF)
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